Cannabidiol mitigates methotrexate-induced hepatic injury via SIRT-1/p53 signaling and mitochondrial pathways: reduces oxidative stress and inflammation
Drug and Chemical Toxicology · 2025
DOI: 10.1080/01480545.2024.2425994 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug and Chemical Toxicology, 2025. Verfasst von Ilter Ilhan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey. Hauptthemen laut MEDLINE: Oxidative Stress, Methotrexate, Chemical and Drug Induced Liver Injury, Cannabidiol. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Methotrexate (MTX), a widely used chemotherapeutic agent, often induces hepatotoxicity, limiting its clinical utility. Cannabidiol (CBD), derived from hemp, possesses antioxidant, anti-inflammatory, and antiapoptotic properties. This study aims to investigate CBD's protective effects against MTX-induced liver injury and elucidate the underlying mechanisms. Thirty-two female Wistar Albino rats were divided into four groups: control, MTX (20 mg/kg intraperitoneally [i.p.] once), MTX+CBD (20 mg/kg i.p. once + 5 mg/kg i.p. for seven days), and CBD (5 mg/kg, i.p. for seven days). Biochemical analyses of serum and liver tissues were performed to assess oxidative stress markers (total oxidant status, total antioxidant status, oxidative stress index), liver function tests (AST, ALT), and antioxidant enzyme activities (glutathione peroxidase, superoxide dismutase). Histopathological and immunohistochemical examinations were conducted to evaluate liver tissue damage and TNF-α expression. Genetic analyses were performed to measure the expression levels of SIRT-1, p53, Bcl-2, and Bax genes using RT-qPCR. MTX administration increased oxidative stress markers, liver enzymes, TNF-α, p53, and Bax levels while decreasing antioxidant defenses and SIRT-1 expression. CBD administration reversed these alterations effectively. CBD mitigated MTX-induced hepatotoxicity by reducing oxidative stress, inflammation, and apoptosis. It activates antioxidant defenses via SIRT-1 upregulation, suppresses inflammation by reducing TNF-α, and prevents apoptosis by modulating p53, Bcl-2, and Bax gene expressions. These findings suggest CBD could be a promising therapeutic agent for chemotherapy-induced liver damage. Further research is warranted to explore additional pathways and broader molecular mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
- Department of Pharmacology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
- Department of Histology and Embryology, Alanya Alaaddin Keykubat University, Antalya, Turkey.
ORCID-Profile: Ilter Ilhan, Halil Asci, Ibrahim Aydın Candan, Mehtap Savran, Orhan Berk Imeci, Mehmet Abdulkadir Sevuk
Zitieren
APA
Ilhan, I., Asci, H., Candan, I. A., Savran, M., Imeci, O. B., & Sevuk, M. A. (2025). Cannabidiol mitigates methotrexate-induced hepatic injury via SIRT-1/p53 signaling and mitochondrial pathways: reduces oxidative stress and inflammation. Drug and Chemical Toxicology. https://doi.org/10.1080/01480545.2024.2425994
Vancouver
Ilhan I, Asci H, Candan IA, Savran M, Imeci OB, Sevuk MA. Cannabidiol mitigates methotrexate-induced hepatic injury via SIRT-1/p53 signaling and mitochondrial pathways: reduces oxidative stress and inflammation. Drug and Chemical Toxicology. 2025. doi:10.1080/01480545.2024.2425994
BibTeX
@article{Ilhan2025,
author = {Ilhan, Ilter and Asci, Halil and Candan, Ibrahim Aydın and Savran, Mehtap and Imeci, Orhan Berk and Sevuk, Mehmet Abdulkadir},
title = {Cannabidiol mitigates methotrexate-induced hepatic injury via SIRT-1/p53 signaling and mitochondrial pathways: reduces oxidative stress and inflammation},
journal = {Drug and Chemical Toxicology},
year = {2025},
doi = {10.1080/01480545.2024.2425994}
}
EUVIMED